Literature DB >> 8682461

Treatments for second malignancies after gastrectomy for stomach cancer.

H Furukawa1, M Hiratsuka, T Iwanaga, S Imaoka, T Kabuto, O Ishikawa, Y Sasaki, M Kameyama, H Ohigashi, S Nakamori.   

Abstract

BACKGROUND/AIMS: Metachronous primary cancers after stomach cancer were reported as a cause of late death. It is necessary to treat these second malignancies to improve the result of surgical treatment for gastric cancer.
MATERIAL AND METHODS: Among 3,570 patients who underwent gastrectomy during 1961-1986, 160 second primary malignancies were observed as of December of 1991. Liver (27 patients) and colorectal (18 patients) cancers were the largest in number.
RESULTS: By the end of 1992, for 32 liver tumors small resection, transcatheter arterial embolization and percutaneous ethanol injection were carried out and 3-year survival of resected cases (6 patients; 80.0%) was better than that of nonresected cases (26; 3.8%) (p < 0.05). In 19 colorectal cancers, surgical resection (13/19) and combined locoregional chemotherapy (2/19) were actively performed, and 5-year survival of resected cases (13; 55.4%) was better than that of nonresected cases (6; 0%) (p < 0.05).
CONCLUSION: With an intensive long-term follow-up after gastrectomy for cancer, early diagnosis and effective therapy for second primary malignancies is improved.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8682461

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  4 in total

1.  Metachronous double primary cancer after diagnosis of gastric cancer.

Authors:  Jin Young Kim; Won Young Jang; Mi Hwa Heo; Kang Kuk Lee; Young Rok Do; Keon Uk Park; Hong Suk Song; Yoon Nyun Kim
Journal:  Cancer Res Treat       Date:  2012-09-30       Impact factor: 4.679

2.  Synchronous and metachronous neoplasms in gastric cancer patients: a 23-year study.

Authors:  Małgorzata Ławniczak; Alicja Gawin; Halina Jaroszewicz-Heigelmann; Wiesława Rogoza-Mateja; Joanna Raszeja-Wyszomirska; Andrzej Białek; Katarzyna Karpińska-Kaczmarczyk; Teresa Starzyńska
Journal:  World J Gastroenterol       Date:  2014-06-21       Impact factor: 5.742

3.  Clinicopathologic features of metachronous or synchronous gastric cancer patients with three or more primary sites.

Authors:  Joo Hoon Kim; Sun Young Rha; Chan Kim; Gun Min Kim; Sang Hyun Yoon; Ki Hyang Kim; Min Jae Kim; Joong Bae Ahn; Hyun Cheol Chung; Jae Kyung Roh; Hyo Song Kim
Journal:  Cancer Res Treat       Date:  2010-12-31       Impact factor: 4.679

4.  Surgical outcome of synchronous second primary cancer in patients with gastric cancer.

Authors:  Tae Kyung Ha; Ji Yeong An; Ho Geun Youn; Jae Hyung Noh; Tae Sung Sohn; Sung Kim
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.